Stocks and Investing
Stocks and Investing
Fri, August 18, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, August 17, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Josh Schimmer Initiated (VYGR) at Buy and Held Target at $21 on, Aug 17th, 2017
Josh Schimmer of Evercore ISI Group, Initiated "Voyager Therapeutics, Inc." (VYGR) at Buy and Held Target at $21 on, Aug 17th, 2017.
Josh has made no other calls on VYGR in the last 4 months.
There is 1 other peer that has a rating on VYGR. Out of the 1 peers that are also analyzing VYGR, 0 agree with Josh's Rating of Hold.
This is the rating of the analyst that currently disagrees with Josh
- Katherine Breedis of "Stifel" Initiated at Strong Buy and Held Target at $20 on, Friday, July 28th, 2017
Contributing Sources